Understanding
macular degeneration.
Clarity for what’s next.

AMD is one possible cause, but a new blurry or missing area cannot be diagnosed online. Contact an eye-care professional right away, especially if straight lines now look bent. Do not assume that sleep, tiredness or needing new glasses explains a sudden change.

Sources: NEI: Age-related macular degeneration · NHS: AMD symptoms

Distorted straight lines can be a sign of a macular problem, including late AMD. Clinicians may call this metamorphopsia. New distortion needs prompt eye assessment, even if it affects only one eye or does not hurt. Other eye conditions can also cause it.

Sources: NEI: Age-related macular degeneration · NHS: AMD symptoms

The macula supplies the detailed central vision used for reading and recognizing faces. Damage can leave a blurred or missing area, so parts of words or faces seem unclear. Tell your eye-care team about a new change rather than simply increasing your glasses strength.

Sources: NEI: Age-related macular degeneration

Early AMD usually has no noticeable symptoms. Intermediate AMD may also be symptom-free, or cause mild central blur and difficulty in dim light. Later disease can cause distortion or a blank central patch. A dilated examination can detect changes before you notice them.

Sources: NEI: Age-related macular degeneration

Get urgent eye-care advice for new distortion, a central dark or missing patch, or suddenly reduced vision. Sudden loss of sight, a curtain across vision, or new flashes with many floaters needs immediate assessment. These signs can have causes other than AMD; do not wait for a routine visit.

Sources: NEI: Age-related macular degeneration · NEI: Floaters

AMD is usually painless. Pain does not need to be present for a serious central-vision change. Conversely, new eye pain or redness should not be explained away as AMD: it may indicate another problem and needs medical assessment, particularly with reduced vision.

Sources: NHS: AMD symptoms

Yes. The eyes can have different stages or types, and one eye may compensate for the other. Ask for the findings in each eye separately. Having late AMD in one eye increases the risk of late disease in the other, so follow-up remains important.

Sources: NEI: Age-related macular degeneration

Drifting threads and cobwebs sound more like floaters than the central blur or distortion typical of AMD. Floaters usually arise in the vitreous gel. The description alone cannot diagnose the cause, and you can have more than one eye condition. New or suddenly increasing floaters need urgent assessment.

Sources: NEI: Floaters · NEI: Age-related macular degeneration

AMD damages the macula, the small central part of the retina responsible for sharp, straight-ahead detail. It becomes more common with age and can make reading, recognizing faces and other close work difficult. It is an eye disease, not simply an inevitable need for stronger reading glasses.

Sources: NEI: Age-related macular degeneration

Dry AMD involves degenerative changes in the macula and usually develops gradually. Wet, or neovascular, AMD involves abnormal blood vessels that can leak and damage the macula more quickly. Wet AMD is a form of late disease. Neither name describes whether the eye feels dry or watery.

Sources: NEI: Age-related macular degeneration

Drusen are deposits beneath the retina. Their size and the surrounding retinal changes help clinicians assess AMD. Finding drusen does not by itself predict severe sight loss. Ask what the findings mean for your stage and monitoring plan rather than interpreting a scan or photograph on its own.

Sources: Cambridge University Hospitals: Dry AMD

Dry AMD is described as early, intermediate or late. Early disease may not affect how you see; intermediate disease may have few symptoms too. Late disease includes geographic atrophy and wet AMD. Your stage is determined by an examination and retinal findings, not symptoms alone.

Sources: NEI: Age-related macular degeneration

GA is an advanced form of dry AMD in which areas of retinal tissue deteriorate. Its effect on reading and other detailed tasks depends partly on where the damage lies, including whether the very center is involved. It is different from the abnormal-vessel leakage of wet AMD.

Sources: NEI: Age-related macular degeneration · Keenan et al.: Supplements and noncentral GA

Yes. Wet AMD can develop in an eye with dry AMD; it is not an inevitable outcome for everyone. New distortion or a central-vision change needs urgent review because wet disease can progress more quickly and has treatment options. Keep the monitoring plan even when your vision feels stable.

Sources: NEI: Age-related macular degeneration

AMD primarily affects central vision and does not usually remove all peripheral, or side, vision. It can still cause substantial visual disability. The course varies, and treatment and vision rehabilitation may help. A diagnosis alone cannot tell you how much sight you will lose or how quickly.

Sources: NEI: Age-related macular degeneration · NEI: Low vision

Risk rises with age, especially after 55. Smoking and a family history also increase risk. These factors do not tell you whether you have AMD today. Regular eye examinations matter because early disease may be present without obvious visual symptoms.

Sources: NEI: Age-related macular degeneration

Family history is a risk factor, so tell your eye-care professional if a parent or sibling has AMD. A family history does not mean you will definitely develop it. Ask about an appropriate examination schedule; preventive high-dose supplements are not automatically recommended just because AMD runs in the family.

Sources: NEI: Age-related macular degeneration · NEI: AREDS / AREDS2 research FAQ

A comprehensive dilated eye examination allows the clinician to inspect the retina and macula. An OCT scan may be added to show detailed retinal structure. Your symptoms, vision testing and findings together help determine the type, stage and next steps. An online picture comparison cannot diagnose AMD.

Sources: NEI: Age-related macular degeneration

Optical coherence tomography, or OCT, is a noninvasive imaging test that creates detailed pictures of the retina. It helps the eye-care team assess the macula and monitor changes. It is not an operation or an injection into the eye. Ask the clinician to explain the findings in plain language.

Sources: NEI: Age-related macular degeneration

If your clinician recommends a grid, use the reading glasses and viewing distance they advise, in good light. Cover one eye at a time and look at the central dot, noticing new bent, missing or blurred lines. Report changes promptly. Use the schedule your eye-care team gives you.

Sources: Cambridge University Hospitals: Dry AMD

No. Home monitoring does not replace a dilated eye examination or scans. Early AMD can have no symptoms, and a home grid cannot establish a diagnosis or stage. Keep your appointments and report a new visual change even if you are unsure whether the grid looks different.

Sources: NEI: Age-related macular degeneration

The schedule depends on the stage in each eye and whether you are receiving treatment. NEI recommends at least annual dilated examinations for early AMD; some patients need closer follow-up. Confirm your own interval. A sudden change should be reported right away rather than saved for the next appointment.

Sources: NEI: AREDS2 supplements · NEI: Eye injections

Drops can make vision blurry and light-sensitive for several hours. Arrange a ride home and bring sunglasses. Follow your clinic’s advice and do not drive while your vision is affected. Dilation is temporary, but it can make everyday visual tasks difficult for a while.

Sources: NEI: Dilated eye exams

There is no general cure that reverses AMD. Treatment can help control wet disease or slow some forms of progression, and low-vision support can make daily tasks easier. The right option depends on the type and stage. Slowing damage is different from restoring retinal tissue that has already been lost.

Sources: NEI: Age-related macular degeneration · FDA: Geographic-atrophy treatment evidence · NEI: Low vision

Anti-VEGF injections are a main treatment. They block a signal involved in abnormal blood-vessel growth and leakage and can help protect, and sometimes improve, vision. A retina specialist chooses a treatment and monitoring schedule. Other treatments, such as photodynamic therapy, may be considered in selected cases.

Sources: NEI: Age-related macular degeneration · NEI: Eye injections

The team numbs and cleans the eye, then gives the medicine with a very small needle. Some irritation can happen afterward. Tell the clinic about your concerns before treatment so they can explain what to expect. Pain or vision problems that worsen after an injection need immediate advice.

Sources: NEI: Eye injections

Many people start with monthly injections, but the medicine, retinal findings and response determine the schedule. Intervals may change over time. Some people need ongoing treatment to protect vision. Keep appointments and contact the clinic before delaying or stopping treatment, even if your sight seems stable.

Sources: NEI: Eye injections

Contact the treating eye team right away for worsening pain or worsening vision after an injection. These can be signs of infection. Mild short-lived irritation or floating air bubbles may occur, but you should use the clinic’s aftercare instructions and urgent contact number if anything concerns you.

Sources: NEI: Eye injections

In the United States, FDA-approved injections can slow geographic-atrophy lesion growth in some patients. They do not restore lost vision and are not a treatment for every stage of dry AMD. Discuss expected benefit, injection burden and risks, including new wet AMD and injection-related complications, with a retina specialist. Availability differs by country.

Sources: FDA: Geographic-atrophy treatment evidence

A 2025 paper reanalyzed AREDS and AREDS2 data and found slower progression toward the central macula in some eyes with noncentral GA. It did not show restored sight or a significant overall reduction in GA-area growth in the analyses reported. This was a post hoc analysis; ask your specialist how it affects your own plan.

Sources: Keenan et al.: Supplements and noncentral GA

AREDS2 may help people with intermediate AMD in one or both eyes, or certain people with late AMD in one eye, reduce the risk of progression in the other. Ask your eye-care professional to confirm eligibility from your retinal findings. The formula is not a universal eye vitamin for everyone.

Sources: NEI: AREDS2 supplements · NEI: AREDS / AREDS2 research FAQ

The trials did not show benefit for people without AMD or with early AMD. Having a family history alone is not an indication for high-dose AREDS2. Keep recommended eye examinations and discuss smoking, activity and diet rather than self-prescribing a clinical-dose formula as general prevention.

Sources: NEI: AREDS / AREDS2 research FAQ · NEI: AREDS2 supplements

NEI lists vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg, copper 2 mg, lutein 10 mg and zeaxanthin 2 mg, with no beta-carotene. These are clinical amounts, not routine dietary targets. Confirm the full formulation and its suitability with your eye-care professional.

Sources: NEI: AREDS2 supplements

They can interact with medicines and overlap with other supplements. The 80 mg zinc amount in the NEI formula exceeds the usual adult upper limit of 40 mg daily; medically supervised use is different from self-dosing. Bring all medicine and supplement labels to your clinician or pharmacist before starting.

Sources: NEI: AREDS2 supplements · NIH ODS: Zinc

The older AREDS formula contained beta-carotene, which was linked to increased lung-cancer risk in people who smoke or used to smoke. AREDS2 uses lutein and zeaxanthin instead. Check the label and discuss any beta-carotene-containing supplement with your clinician, even if you stopped smoking years ago.

Sources: NEI: AREDS2 supplements · NEI: AREDS / AREDS2 research FAQ

A healthy diet is valuable, but food and standard multivitamins do not reproduce the clinical formula tested for specific AMD stages. Conversely, needing a better diet does not automatically mean you need AREDS2. If it is recommended for your stage, ask before replacing it with a food or another supplement.

Sources: NEI: AREDS2 supplements · NEI: AREDS / AREDS2 research FAQ

NEI recommends a healthy eating pattern that includes leafy green vegetables and fish, alongside physical activity, not smoking and healthy blood pressure and cholesterol. No single food reverses AMD. If you take warfarin, keep vitamin K intake consistent and discuss major changes to leafy-green intake with your clinician.

Sources: NEI: Age-related macular degeneration · NIH ODS: Vitamin K

Adjustable task lighting, magnifiers, larger type and stronger contrast can help you use your remaining vision. Phones and computers also offer zoom and text-to-speech. A low-vision assessment can match tools and training to your needs instead of leaving you to guess which device to buy.

Sources: NEI: Low vision

An updated prescription may help a separate focusing problem, but ordinary glasses do not repair macular damage. Low vision is vision loss that regular glasses, contacts or standard treatment cannot fully correct. Ask about rehabilitation and assistive tools as well as whether your prescription needs updating.

Sources: NEI: Low vision

That depends on your actual vision and local licensing requirements, not just the diagnosis. Central-vision loss can affect safe driving. Discuss your vision with your clinician and the relevant licensing authority; do not drive if you cannot see safely. Plan alternatives early if driving is becoming difficult.

Sources: NEI: Age-related macular degeneration · NEI: Low vision

Some people with significant sight loss experience visual hallucinations called Charles Bonnet syndrome. It is not itself dementia or a mental health disorder, but hallucinations need medical assessment to exclude other causes. Tell your clinician promptly, especially if this is new or has changed.

Sources: NHS: Charles Bonnet syndrome

Ask which tasks are difficult and what help the person wants. Support can include transport to appointments, accessible reading settings and a referral for vision rehabilitation. Encourage independence and discuss emotional strain with the care team; sight loss affects more than an eye-chart score.

Sources: NEI: Low vision